Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Large-vessel vasculitis.

Kathleen Maksimowicz-McKinnon1, Gary S Hoffman

  • 1Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. kmaxdo@hotmail.com

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary

Large-vessel vasculitis presents diagnostic challenges due to non-specific markers and impractical biopsies. This review aids recognition, outlines pulmonary manifestations, and provides evidence-based therapeutic guidelines for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infections in Vasculitis: Can We Create an Epidemic of Change?

The Journal of rheumatology·2024
Same author

Sorting out aortic aneurysms: A team enterprise.

Cleveland Clinic journal of medicine·2024
Same author

Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.

The Lancet. Rheumatology·2024
Same author

The Impact of Global Collaboration on the Academic Focus of the West African College of Surgeons: Are Worldwide Efforts Aligning with Local Priorities?

World journal of surgery·2023
Same author

Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.

Annals of the rheumatic diseases·2022
Same author

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2021

Area of Science:

  • Rheumatology and Immunology
  • Vascular Medicine

Background:

  • Large- and medium-vessel vasculitides, including giant cell arteritis and Takayasu's disease, are a heterogeneous group of inflammatory disorders.
  • Diagnosis of large-vessel vasculitis is often challenging due to elusive clinical presentations, non-specific serologic markers, and impracticality of tissue biopsies.
  • Pulmonary manifestations are common but often under-recognized in the initial evaluation of these conditions.

Purpose of the Study:

  • To aid in the recognition of large-vessel vasculitis by emphasizing common disease manifestations.
  • To highlight prevalent pulmonary manifestations associated with these vasculitides.
  • To provide evidence-based therapeutic guidelines for managing patients with large- and medium-vessel vasculitis.

Main Methods:

Related Experiment Videos

  • Review of rigorously conducted, clinically relevant large cohort studies and randomized controlled trials.
  • Emphasis on common clinical and pulmonary manifestations to improve diagnostic accuracy.
  • Focus on evidence-based therapeutic approaches rather than isolated case reports.
  • Main Results:

    • Identification of key clinical features suggestive of large-vessel vasculitis.
    • Characterization of common pulmonary involvement patterns.
    • Synthesis of data to inform initial therapeutic strategies.

    Conclusions:

    • Early recognition of characteristic manifestations is crucial for timely diagnosis of large-vessel vasculitis.
    • Evidence-based therapeutic guidelines, with careful consideration of potential complications, are essential for optimal patient management.
    • Effective monitoring of disease activity is critical to minimize long-term morbidity and mortality associated with vasculitis and its treatment.